CLINICAL TRIAL: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE SAFETY OF LONG-TER

临床试验：评估长期安全性的随机对照试验

• 批准号: 7982097
• 负责人: KAREN L LINDSAY
• 金额: $ 13.57万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7982097
• 关键词: Chronic Hepatitis C; Cirrhosis; Clinical Research; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Fibrosis; Funding; Grant; Histologic; Institution; Liver diseases; Patients; Primary carcinoma of the liver cells; Randomized Controlled Trials; Research; Research Personnel; Resources; Risk; Safety; Source; United States National Institutes of Health; interferon therapy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of the study is to conduct a randomized, controlled trial to determine if long-term interferon therapy can reasonably reduce the risk of histologic progression to cirrhosis, decompensated liver disease and/or hepatocellular carcinoma in patients with chronic hepatitis C and advanced fibrosis or cirrhosis who failed to respond to previous interferon therapy.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的主要目的是进行一项随机对照试验，以确定长期干扰素治疗是否可以合理地降低对以前的干扰素治疗无效的慢性丙型肝炎和晚期纤维化或肝硬化患者的组织学进展为肝硬变、失代偿性肝病和/或肝细胞癌的风险。